Fortis Healthcare Limited — Investor Meet, 14-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. Financial Performance: Fortis Healthcare has reported consolidated revenues of INR 1,928 crores for the quarter, growing 14.8% year-over-year, with the Hospital segment contributing INR 1,623 crores (16.8% growth) and Diagnostics showing modest growth from INR 331 crores to INR 342.3 crores. Operating EBITDA increased by 32% to INR 375 crores, enhancing the margin to 19.4% vs. 16.9% in the prior year. Profit after tax before exceptional items surged 82.2% to INR 231 crores.

2. Future Outlook and Growth Drivers: Management expressed confidence in leveraging the robust balance sheet to explore growth opportunities, including expansion and strategic acquisitions aligned with their cluster strategy. Expectation of sustained growth from key specialties in the Hospital segment and operational enhancements were emphasized.

3. Order Book and Operational Updates: The hospital occupancy improved to 67% vs. 64% last year, with ARPOB rising 9.9% to INR 2.45 crores annually. Notably, 11 facilities achieved operating EBITDA above 20%. Fortis also divested the Richmond Road Hospital to consolidate operations and enhance profitability.

4. Analyst Q&A Insights:

- Revenue and Profitability: Analysts inquired about revenue projections and the impact of specialty case mix on profitability, with management confirming minor price increases contributing to the ARPOB.

- Market Position: Management reiterated the focus on acquiring quality assets and expanding both organically and via M&A, with ongoing evaluations of potential opportunities.

- Operational Challenges: Concerns were raised regarding the Manesar greenfield expansion, currently generating INR 5 crores/month, with breakeven anticipated by Q1 of the next fiscal year.

- Capex Plans: Total capex guidance is set at INR 900 crores for the year, emphasizing brownfield expansions and maintenance.

5. Market or Regulatory Updates: No significant regulatory changes were discussed, but the company is actively engaged in adapting to market dynamics, emphasizing operational efficiency amid competitive pressures.

6. Strategic Focus Areas: Management emphasized a dual focus on organic growth through hospital expansion and acquisitions. Continuous improvement in operational metrics and focus on digital channels were highlighted as key strategic themes.

7. Investor Insight: Fortis Healthcare showcases robust financial health and a solid growth trajectory, signaling potential for a ‘buy’ position. However, investors should be mindful of operational challenges tied to new expansions and competitive pressures in the healthcare sector. Long-term strategies appear well-aligned with anticipated market trends, positioning the company favorably for sustainable growth.